About this Episode
Dr Joaquim Bellmunt from the Beth Israel Deaconess Medical Center in Boston discusses the use of immune checkpoint inhibitors in urothelial bladder carcinoma.
CME information and select publications here.
Dr Joaquim Bellmunt from the Beth Israel Deaconess Medical Center in Boston discusses the use of immune checkpoint inhibitors in urothelial bladder carcinoma.
CME information and select publications here.